Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit

BERWYN, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces the promotion of Donovan Quill to chief strategy officer, Life Sciences, and Bob Gilkin, RPh, MBA, to chief commercial and growth officer. In their new positions, Donovan and Bob serve dual appointments, continuing in their leadership roles at AscellaHealth while contributing to the growth of Actum Pharma as an affiliate organization that helps companies fund, develop, manage and market novel, life-changing therapies.

Bill Oldham, president and chairman, AscellaHealth, says, “For years, we’ve observed multiple companies struggle to navigate business complexities as they pursue their mission: helping patients and families access life altering therapies. By integrating the strengths of AscellaHealth and Actum, we can offer high-value opportunities for emerging biopharma companies as well as established specialty pharmaceutical manufacturers, whether they are launching new therapies or positioning existing products for increased market share. Together, we offer a fresh approach to uncovering operational gaps and bringing untapped resources and expertise to accelerate market success.”

Quill, an industry veteran and rare disease advocate, shares, “I started my career in life sciences because of the impact of a rare disease, Alpha-1, had on my own family. Since then, I have had an unwavering passion for ensuring new treatments effectively reach their intended patient populations. Taking on a leadership role with Actum Pharma provides an exciting opportunity for me to bring that passion to clinical stage companies while continuing my work with in-market therapies that require specialty distribution and patient services.”

Gilkin, who launched his career as a registered pharmacist, adds, “Recent scientific breakthroughs, particularly in rare diseases, have been astounding. But, to have real impact for patients we need to meet these scientific breakthroughs with equally innovative market strategies, from capital management and payer solutions to alternative distribution and therapy administration models. This dual appointment with Actum Pharma will not only enable us to help our clients remove bottlenecks to success but also develop new models that pave the way for future therapies.”

The new appointments build upon the recent addition of senior executives to the AscellaHealth team, including Clayton Edwards, RPh, MBA, senior vice president, Payer Business Unit and Carl T. Bertram, PharmD, MS, MBA, senior vice president, Pharma Business Unit. Additionally, Lisa Crowley was promoted to senior vice president of human resources and workforce development/chief of staff. These experienced professionals reinforce a commitment to delivering tailored, high-value end-to-end solutions that support specialty pharmaceutical product commercialization, improved patient access to novel therapies and optimal clinical outcomes.

About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. Visit www.AscellaHealth.com.

About Actum Pharma
Actum Pharma, a strategy and operating business partner to global biopharma manufacturers, is founded and led by industry leaders with a mission to solve an addressable problem in life sciences: the failure of scientifically viable, life-changing therapies to achieve success due to avoidable market missteps. Through a unique operating partner model, Actum helps companies fund, develop, manage and market novel therapies through a portfolio of proven business solutions that accelerate market success. Visit www.actumpharma.com.

This press release was published by a CLEAR® Verified individual.


Media:
Caroline Chambers
CPR Communications
Cchambers@cpronline.com
201-641-1911 ext 21

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.